Balancing The Scales: The Ups And Downs Of Bioprocess Scale-Up
Dry Powder Inhalable Vaccines For Shelf Stability And Global Access
Navigating Your Holistic Approach To CCI For Biologic Drug Products
Accelerating Drug Development For Biologics: Flexible And Fast DNA-To-IND Programs
Leveraging Platforms To Create Vaccines At Pandemic Speed
Accelerate Your Bispecific Antibody Development
How Does bYlok Technology Work? How Can It Improve Bispecific Production?
Solving Bispecific Antibody Heavy-Light Chain Mispairing
Particle Investigation: Going One Step Further Than Just The Identification
Expressing Next-Gen Immunotherapies And Other Advanced Biologics
Development, Manufacture Of Biopharmaceuticals In Microbial Systems
Harnessing New Tech To Create Next-Generation GS-CHO Expression Solutions
In Silico, In Vitro Tools For Regulatory Submission, Feedback
Overcoming The Challenges In Fabs And Fc-Fusion Development Programs
How To Bring (Any) mRNA To Life: Simplifying Nucleic Acid Encapsulation
Pionyr: Selecting A CDMO To Scale-Up Manufacturing
Early Developability And Analytical Toolbox For The Production Of Multi-Chain Biotherapeutics
Effective Technology Transfer For Mammalian Derived Biopharmaceuticals
Precision Execution Of Bispecifics At Scale From Design To Delivery
Embrace Molecule Complexity With Optimized Expression Technologies
Tailored CMC Solutions That Meet Needs Of Novel Molecular Biologic Formats
Reaching BLA Success: Fast-Track Approach To Process Characterization
Our Biotech Success — Levicept
Challenges Associated With In-Use Simulated Administration Of Biologics
Mitigate Risk Of Failure In Biotherapeutic Development
Improved Design And Production Of Bispecific Therapeutics
Developing A mAb For A Small Biotech Developing Precision Medicines
Addressing Key Challenges Of High Concentration Formulation Development
Hybrid Approach For Optimizing Transient Protein Expression In CHO Cells
Predictive Modeling Of Concentration-Dependent Viscosity Behavior
Filling The Need For Integrated Bioconjugate Solutions
Analytical Strategies To Address Common Development Challenges
Challenges Of Moving A Bioconjugate Candidate From Clinic To Market
Our Biotech Success — Surrozen
Inclusion Bodies: Mother Nature's Help Or Hindrance?
Achieving Biologics License Application Success Using A Structured Approach
Trends, Challenges, And Opportunities In Bispecific Antibodies
Process Intensification To Improve Efficiency, Productivity
CMC Strategy To Take Bispecifics From DNA To IND In 13 Months
DNA To IND In 11 Months: Integrated Drug Substance, Drug Product Offering
Optimizing The Path To First-In-Human Clinical Trials: Design And De-Risk
Best Tech Transfer Practices To Optimize Clinical And Commercial Supply
Drug Product Process Characterization For Liquid And Lyophilized DP
Identifying And Mitigating Potential For Immunogenicity, Immunotoxicity
Early Development To Clinic – De-Risking A Bioconjugate's Journey
Key Enablers For Late Phase Biologic Drug Development, Launch
Overcome Manufacturability, Expression, Early Material Generation Challenges
Deciphering mRNA Immunogenicity: Early Assessment Of Human Immune Response
Scalable Protein Expression With Pichia Pastoris
How To Safely Handle Your Antibody Drug Conjugate
Pharmaceutical Spray Drying: Sustainable Commercial Best Practices
Meeting The Challenge Of Rising API Complexity
Continuous Flow Techniques For Fine Chemical Manufacturing
Environmental Sustainability: Use Case - Solvent Recovery
Rapid, Material-Sparing Feasibility Screening For Hot Melt Extrusion
Chromatography, Purification & Isolation Technologies
Rapid Development Of Amorphous Solid Dispersions For Bioavailability
How To Design An HPAPI Plant And Its Containment Systems
How To Deal With The Complexity Of Drugs In Clinical Development
Particle Size Control Through Micronization: Challenges And Solutions
Dramatic Reduction Of Solvent Usage In Pharmaceutical Spray Drying
PBPK Modeling: Mitigating Absorption Risks In Early Drug Development
Process Re-Design For Sustainability In Small Molecule Manufacturing
Simultaneous Spray Drying: Dry Powder Inhaler Combination Formulations
From Powder To Particles With Jet Milling
Local Delivery For Treatment Of Lung Cancer
Increase Spray Drying Throughput For Brick Dust Compounds
Identify And Mitigate Absorption Risks With PBPK Modeling
Environmental Sustainability: Wastewater Incineration Reduction
Solid Form Screening Of Active Pharmaceutical Ingredients
Streamlined Selection Of In Vivo Predictive Dissolution Media
Secure And Industrialize Your CGT Process Towards cGMP Manufacturing
Path To IND: AAV Transient Transfection, Producer Cell Line Platforms
Preparing For FDA Pre-Approval Inspection: Quality And Regulatory Topics
The CDMO Value Proposition For Your Autologous Cell Therapy
An End-To-End Industrialization Roadmap For Autologous Cell Therapy
De-Risk Your Path To Clinic With An AAV Suspension Platform
Scale-Up Allogeneic Cell Therapies To Large Patient Populations
Improved And Rebalanced Plasmids To Ramp Up Your AAV Productivity
Scalable Suspension LVV Production Platforms
Keys To A Successful cGMP Manufacturing Operation Delivering CGTs
